Clinical Trial Update: Expanded Dryvax Dilution Study in Previously Vaccinated Adults [Phase 2]

View source ↗

Summary

A Phase 2 trial update for an expanded Dryvax dilution study in adults who were previously vaccinated against smallpox; the study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Smallpox

Drugs mentioned

• Dryvax (Vaccinia virus vaccine)

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Smallpox | Phase 2 | Status: COMPLETED